Best Peptides for Sleep: An Evidence-Based Guide to DSIP, Epitalon, Selank, and the GH Stack

If you have stared at the ceiling at 3 a.m. for a year and a half, you already know that the "sleep hygiene" checklist is not the answer. Cool room, no screens, magnesium glycinate, blackout curtains -- the basics matter, but the basics do not move the needle for everyone. A growing body of clinical research has, quietly, shifted attention to a different layer of intervention: short, sequence-specific peptides that act directly on the sleep architecture machinery in the brain.

This guide is the most thorough survey we know of on the peptides currently being researched for sleep. We will cover the mechanism behind why sleep falls apart in the first place, which peptides have the strongest data behind them, how researchers structure protocols, what stacks tend to synergize, and what to watch out for. Everything is sourced to peer-reviewed work, and we will say so clearly when something is anecdotal versus when it is replicated in clinical trials.

A note before we start: nothing here is a prescription, and the regulatory status of these compounds varies by jurisdiction. We will get into the legal landscape at the end. Read the legal status of peptides by country before sourcing anything.

Why sleep falls apart in the first place

To understand why a peptide approach can work where ten different sleep aids have not, it helps to look at what is actually breaking down.

Adult sleep is governed by two systems that operate in parallel: the circadian process (Process C), which tells your body what time it is, and the homeostatic process (Process S), which tracks how long you have been awake and accumulates "sleep pressure" in proportion. Both of these systems can fail in characteristic ways.

Process C runs on melatonin, cortisol, and core body temperature. It depends on bright morning light to anchor itself, on darkness in the evening to disinhibit melatonin secretion from the pineal gland, and on a stable schedule. When melatonin amplitude flattens with age (it falls by roughly 50% between age 20 and age 60), or when light exposure is inverted because of shift work or international travel, Process C decouples from the actual day-night cycle and you get fragmented sleep that no amount of "sleep hygiene" fully repairs.

Process S, the homeostatic side, is harder to see but easier to manipulate. It is driven in part by adenosine accumulation in the basal forebrain and by something more interesting: a slow-wave-sleep-promoting neuropeptide system that includes the delta-sleep-inducing peptide, or DSIP. We will get to DSIP shortly.

The third layer that breaks down with age is the growth hormone pulse. Most of your daily GH secretion happens during the first 90-minute slow-wave block of the night. From your twenties through your sixties, that pulse compresses and weakens. The relationship is bidirectional: deeper slow-wave sleep produces a bigger GH pulse, and a healthy GH pulse helps to consolidate slow-wave sleep on subsequent nights. When the pulse weakens, the sleep architecture frays, and the fraying further weakens the pulse. That is the trap.

A fourth layer is stress-axis dysregulation. Chronically elevated evening cortisol -- the classic profile of someone with poor sleep -- inhibits adenosine signaling and suppresses melatonin onset. The body, biochemically, refuses to power down.

Each of these failure modes maps onto a different peptide class. That is why "the best peptide for sleep" depends on what is actually wrong with your sleep.

How peptides address sleep at the mechanism level

Sleep-active peptides act through four broad mechanisms:

1. Direct slow-wave promotion. DSIP and, to a lesser extent, Epitalon increase the duration and amplitude of delta-wave (deep) sleep.
2. GH pulse amplification. Growth-hormone-releasing peptides (GHRPs like ipamorelin) and GHRH analogs (CJC-1295, sermorelin) restore the night-one GH pulse, indirectly deepening slow-wave sleep.
3. Anxiolytic, parasympathetic shift. Selank (and to a degree Semax, though it is more daytime-oriented) reduces pre-sleep autonomic arousal without sedation.
4. Circadian / melatonin axis restoration. Epitalon directly modulates pineal function and has been shown in multiple Russian clinical studies to restore melatonin amplitude in older adults.

The peptides we will cover below sit somewhere on this map. Most of the strongest stacks pair one mechanism-1 or mechanism-4 agent with one mechanism-2 agent, because slow-wave sleep is what GH secretion piggybacks on.

If you want to dig deeper on architecture itself, see how peptides improve deep sleep rem.

The shortlist: peptides with the strongest evidence for sleep

DSIP (Delta Sleep-Inducing Peptide)

DSIP is a nine-amino-acid neuropeptide first isolated in 1977 by Schoenenberger and Monnier from the cerebral venous blood of rabbits in induced delta sleep. The sequence is Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. It has been studied for nearly five decades, most prominently in Russian and German labs.

Mechanistically, DSIP appears to act on the basal forebrain and the locus coeruleus, dampening adrenergic tone and increasing the duration of slow-wave sleep stages 3 and 4. It does not produce sedation in the way a benzodiazepine does. Subjects do not report grogginess or "knocked out" feelings -- the effect is a deeper, more consolidated version of the sleep one would have anyway. That is part of what makes it interesting.

Clinical evidence is mixed but largely positive. Schneider-Helmert and Schoenenberger (1983) reported significant improvements in sleep quality in chronic insomniacs given intravenous DSIP across multiple consecutive nights (PMID: 6342827). A later double-blind trial in chronic insomniacs likewise showed improved sleep efficiency and reduced nocturnal awakenings (Schneider-Helmert, Pharmacopsychiatry, 1985). Counter to that, several smaller crossover studies have failed to find effects on objective polysomnographic outcomes, particularly when DSIP was administered late in the evening rather than at sleep onset. The conclusion most researchers settle on is that DSIP is real but timing-sensitive.

Typical research protocols are intranasal or subcutaneous, 100-300 mcg administered 30-60 minutes before lights out, three to five nights per week for two to four weeks. See dsip dosage and timing guide for the full breakdown.

DSIP is well tolerated in published work. Headache and mild nausea are the most commonly reported issues at the high end of the dose range.

Epitalon (Epithalon)

Epitalon is a tetrapeptide (Ala-Glu-Asp-Gly) synthesized in the 1990s by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It was designed as a synthetic analog of a peptide isolated from the pineal gland.

The reason Epitalon belongs on a sleep list is not that it is a sedative -- it isn't -- but that it appears to restore pineal melatonin secretion in older adults whose melatonin amplitude has flattened. In a 2007 study by Korkushko et al. (PMID: 17415480), elderly patients given Epitalon over six months showed a significant restoration of nighttime melatonin amplitude and a normalization of circadian rhythms compared to placebo. Anisimov and Khavinson's group has also published extensively on Epitalon's apparent telomerase-activating effects in human somatic cells, which is the lever for the anti-aging interest, but for our purposes the circadian effect is what matters.

The classic Epitalon protocol is 5-10 mg subcutaneously, daily for 10-20 consecutive days, repeated 2-3 times per year. Many practitioners run it in a "loading course" in the spring and fall, on the rationale that those are the seasons of biggest circadian disruption. See epitalon sleep cycle melatonin.

Epitalon does not deepen any one night of sleep the way DSIP does. It instead recalibrates the system over weeks. If you are over 40 and your sleep has been fragmenting in a way that feels age-related rather than stress-related, Epitalon is the peptide most often cited.

Selank

Selank is a synthetic heptapeptide developed by the Russian Institute of Molecular Genetics, designed as an analog of the immunomodulatory peptide tuftsin. Its primary clinical application is as an anxiolytic, but its anxiolytic profile is the reason it ends up on sleep stacks.

Unlike benzodiazepines, Selank does not produce sedation, motor impairment, or dependency, but it consistently reduces measures of anxiety in both animal and human studies (Medvedev et al., 2015, PMID: 26726302). It modulates GABAergic and serotonergic systems and increases BDNF expression. For people whose insomnia is driven by ruminative pre-sleep anxiety, Selank is often more useful than a direct sleep agent because it addresses the input rather than the output.

Selank is typically administered intranasally at 250-500 mcg per dose, two to three times per day, with the last dose 1-2 hours before bed. Cycles of 10-14 days are typical, repeated as needed. See selank for anxiety sleep.

It has an excellent safety record. The most commonly noted issue is a slight dampening of motivation if dosed too high -- the dose-response curve is non-monotonic, which is to say more is not better.

CJC-1295 and Ipamorelin (the GH stack)

The combination of a GHRH analog (CJC-1295) with a selective GHRP (ipamorelin) is, on the published evidence, the single most reliable way to amplify the natural overnight growth hormone pulse. We get into the comparison in detail at cjc 1295 vs sermorelin and at cjc 1295 ipamorelin bedtime protocol; here we just need the sleep relevance.

A bedtime injection of CJC-1295 (without DAC, typically 100 mcg) plus ipamorelin (typically 100-300 mcg) about 30 minutes before lights out reliably produces a robust GH pulse during the first slow-wave block of the night. Teichman et al. (2006, PMID: 16352683) demonstrated that CJC-1295 with DAC produced sustained increases in GH and IGF-1 in healthy adults; ipamorelin's selective profile (it does not significantly raise cortisol or prolactin, unlike GHRP-6) is documented in Raun et al. (1998, PMID: 9849822).

Practically, people on this combination report longer subjective sleep, more vivid dreams (consistent with REM rebound and a stronger SWS-to-REM transition), and that classic "I slept like a teenager" feeling that the GH-deficient adult population in particular tends to lose.

It is worth being honest: this is the stack with the most upside and the most considerations. It is a hormone-axis intervention, not a one-off sleep aid. Cycle structure, food timing (you want a fasted state for two hours pre- and 30 minutes post-injection to avoid blunting the pulse with elevated somatostatin), and individual responsiveness all matter. We cover all of it in the cluster article above.

MOTS-c

MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within the 12S rRNA gene, identified by the Cohen lab at USC in 2015. Its primary mechanism is metabolic -- it activates AMPK and improves insulin sensitivity (Lee et al., Cell Metabolism, 2015, PMID: 25738459). The sleep relevance is indirect but real: people whose poor sleep is driven by metabolic dysregulation (late-night reactive hypoglycemia, elevated nighttime cortisol secondary to insulin resistance, persistent fatigue from impaired mitochondrial energetics) often report dramatically better sleep on a MOTS-c protocol.

MOTS-c is typically dosed at 5-10 mg subcutaneously, two to three times per week, in 8-12 week cycles. See mots c mitochondrial function.

This is not a first-line sleep peptide. It is what you reach for when the sleep problem turns out to be a metabolic problem in disguise.

Cerebrolysin (off-label adjunct)

Cerebrolysin is a porcine-brain-derived mix of low-molecular-weight neuropeptides and amino acids, used clinically in Europe and Asia for stroke recovery and dementia. It is included here as a footnote rather than a recommendation -- there is a small clinical literature on its use in age-related sleep architecture decline (Alvarez et al., 2011, PMID: 21425947, in dementia patients), and some clinicians use it as an adjunct for older adults whose cognitive decline is correlated with sleep fragmentation. It is not a sleep peptide per se. See cerebrolysin stroke recovery if you want the broader picture.

Stacking: combinations that synergize, and combinations to avoid

The principle: pair a mechanism-1 or mechanism-4 agent (architectural deepener) with a mechanism-2 agent (GH pulse amplifier). Do not stack two GH pulse agents together -- you will burn through receptor sensitivity faster and not gain much amplitude.

Synergistic combinations:

Combinations to avoid or be careful with:

• Two GHRPs in the same window (e.g. ipamorelin + GHRP-6). You will not get additive GH release; you will saturate the receptor.
• A GH stack with a high-carbohydrate evening meal. Elevated insulin and somatostatin will blunt the pulse you are trying to produce. Eat your last meal at least two hours before the injection, ideally three.
• DSIP with alcohol. There is no formal interaction study, but alcohol independently fragments sleep architecture; layering DSIP underneath does not rescue it and may produce flat, unrefreshing sleep.
• PT-141 in the evening if you also want to sleep. PT-141 is a melanocortin agonist with a long enough half-life that an evening dose can produce arousal-driven wakefulness three hours later. See pt 141 side effects nausea.

For a fuller treatment of how peptides stack across goals, peptide stack for insomnia is the deepest dive on the site.

Protocols: beginner, intermediate, advanced

The protocols below are summaries of approaches that appear repeatedly in the literature and in practitioner reports. They are not prescriptions.

Beginner: single-peptide trial (4 weeks)

The simplest test of whether peptides will help your sleep is a single-agent trial. Pick one peptide, isolate the variable, observe.

• Pick: DSIP if your problem is shallow or fragmented sleep. Selank if your problem is bedtime anxiety. Epitalon if you are over 40 and your melatonin pattern feels off.
• Duration: 14-21 days of continuous use, then a one-week washout, then evaluate.
• Measurement: subjective Pittsburgh Sleep Quality Index (PSQI) scoring weekly, plus an Oura ring or Whoop for HRV and slow-wave duration.

If you see a clear change in week two that does not persist after washout, you have a signal. If you see nothing in three weeks, the answer for you is probably architectural (try a GH stack) or upstream (anxiety, light, schedule).

Intermediate: layered architecture-and-GH stack (8-12 weeks)

For people whose sleep is broken in multiple places at once -- shallow AND short AND GH-pulse-flat.

• DSIP, 200-300 mcg, intranasal or subcutaneous, 30 min before lights out, five nights per week.
• CJC-1295 (no DAC), 100 mcg + Ipamorelin, 200 mcg, subcutaneous, 30 min before lights out, five nights per week. Fasted two hours pre-, 30 min post-.
• Off two nights per week to preserve receptor sensitivity.
• 8-week run, 2-week washout, re-evaluate.

This is the protocol that most reliably produces the "I had forgotten what sleep was supposed to feel like" report.

Advanced: full layered protocol (12-16 weeks, ages 45+)

For older adults whose sleep failure is metabolic, circadian, AND architectural.

• Epitalon, 10 mg subcutaneous, daily for 20 days at the start of the protocol (loading dose).
• DSIP, 200 mcg, three nights per week, weeks 1-12.
• CJC-1295/Ipamorelin pair as above, five nights per week, weeks 1-12.
• MOTS-c, 10 mg subcutaneous, twice per week, weeks 1-12.

Then a 4-week washout. Most practitioners will repeat the protocol seasonally rather than continuously, on the rationale that perpetual GH pulse amplification probably erodes some natural reserve.

For the full discussion of how cycling preserves receptor sensitivity, see peptide cycling and receptor downregulation.

What the research actually shows: an honest survey

The published evidence base for sleep peptides is uneven. Here is a candid scorecard:

The peptide most over-claimed in popular sources, in our reading, is Epitalon -- the anti-aging case is interesting but the human evidence sits almost entirely with one research group. We include it because the mechanism is plausible and the sleep-specific finding (restored melatonin amplitude) is one of the more clinically meaningful results; but we are not going to call it "proven."

The peptide most under-appreciated, again in our reading, is Selank, because the anxiety-to-sleep pathway is the most tractable input for the largest share of insomnia cases and Selank's tolerability profile is excellent.

Safety, side effects, contraindications

The peptides discussed here have, on balance, favorable safety profiles in the published research. That said:

• DSIP: mild headache or nausea at high doses; no serious adverse events reported in the published trials.
• Epitalon: essentially no reported adverse events in the Khavinson group's long-term studies, but those studies are not blinded against external replication. Caveat emptor on the safety claim.
• Selank: dose-dependent flattening of affect at very high doses (above 1500 mcg/day in research reports). No dependency, no withdrawal.
• CJC-1295 + Ipamorelin: the most common side effect is injection-site redness. Theoretical concerns: long-term GH/IGF-1 elevation, insulin sensitivity changes, water retention. Anyone with active cancer, uncontrolled diabetes, or a history of pituitary disease should not use GH-axis peptides without a clinician.
• MOTS-c: mild flushing and energy upticks during the first week are commonly reported. Long-term safety data in humans is still limited.
• Cerebrolysin: porcine-derived; not for anyone with relevant allergies or religious dietary restrictions.

Anyone considering an extended protocol (more than 8 weeks) should have a baseline blood panel including IGF-1, fasting insulin, A1c, prolactin, cortisol, and a comprehensive metabolic panel. Recheck at the 6-week mark. See coa certificate of analysis what to look for for sourcing-quality considerations -- many "side effects" reported in online communities turn out to be contamination from low-purity vendors, not the peptide itself.

Sourcing and quality: what to look for

The peptide market is uneven. The single most important quality signal is a batch-specific Certificate of Analysis (COA) produced by a third-party lab, showing:

• Identity confirmation by HPLC-MS (mass spectrometry)
• Purity = 99.0% by HPLC
• Endotoxin level (for injectables) below the relevant pharmacopeial threshold
• Acetate / TFA counterion content disclosed (this matters for accurate dosing)

A vendor that publishes only a "purity certificate" with no methodology, no batch number, no mass spec trace, and no lab name is essentially asking you to trust a marketing claim. Don't.

For long deeper dives on this, see how to spot counterfeit peptides and peptide purity 99 vs 98 percent. The peptide.best marketplace requires every listed vendor to submit a COA per batch; that is the entire reason we exist.

FAQs

How long until peptides start improving sleep?

For DSIP and Selank, most people who respond report changes within 3-7 nights. For Epitalon and the GH stack, the felt improvement usually arrives in weeks 2-3 and consolidates by week 4.

Can I take sleep peptides every night indefinitely?

The honest answer is that nobody has done a 5-year trial. The pragmatic approach is to cycle: 8-12 weeks on, 2-4 weeks off, then reassess. This preserves receptor sensitivity (especially for GH peptides) and gives you a natural read on whether the effect is durable.

Are sleep peptides addictive?

None of the peptides covered here produce dependence or withdrawal in the published literature. They are not GABA modulators (the addiction-prone class). This is one of their strongest selling points relative to z-drugs and benzodiazepines.

Can I combine peptides with melatonin?

Yes, in principle, though if you are running Epitalon the point is largely to restore your own melatonin production, which makes exogenous melatonin redundant. Low-dose melatonin (0.3-0.5 mg) plus DSIP is a reasonable combination if your problem is sleep onset specifically.

Can I combine peptides with prescription sleep medications?

Talk to your prescribing clinician. The peptides covered here do not have known major interactions with z-drugs, benzodiazepines, or trazodone, but the goal of a peptide protocol is usually to reduce dependence on those medications, not to layer them.

Do sleep peptides work for shift workers?

Yes, but the protocol differs. See shift worker peptide protocol for the dedicated guide. Briefly: Epitalon plus Selank, with the GH pair shifted to the start of the main sleep block (which may be at 9 a.m.), is the most common framework.

What about oral peptides for sleep?

Most peptides discussed here are not orally bioavailable in their unmodified form. DSIP, Selank, and Semax can be administered intranasally with reasonable bioavailability; the GH peptides essentially require injection. See oral vs injectable peptides for the full pharmacokinetic story.

Will sleep peptides help if my insomnia is caused by sleep apnea?

No. Untreated sleep apnea will defeat any peptide protocol because the architectural problem is mechanical, not biochemical. Get an apnea workup first.

Do I need a prescription?

Regulatory status varies. In the US, most peptides on this list are sold "for research use only" by non-pharmaceutical suppliers; some (e.g. tesamorelin, semaglutide) are prescription pharmaceuticals. See the legal table at legal status of peptides by country for jurisdiction-specific guidance.

References

1. Schneider-Helmert D, Schoenenberger GA. *Effects of DSIP in man*. Pharmacopsychiatry. 1983. PMID: 6342827.
2. Schneider-Helmert D. *Clinical evaluation of DSIP*. Pharmacopsychiatry. 1985.
3. Korkushko OV, Khavinson VKh, Shatilo VB, Antonyk-Sheglova IA. *Peptide geroprotector from the pituitary gland inhibits rapid aging of elderly people: results of 15-year follow-up*. Bull Exp Biol Med. 2011. PMID: 21808782.
4. Korkushko OV, Khavinson VKh, et al. *Effect of peptide preparation Epithalamin on melatonin level and circadian rhythms in elderly*. Bull Exp Biol Med. 2007. PMID: 17415480.
5. Medvedev VE, Tereshchenko OY, et al. *Selank in the treatment of generalized anxiety disorder*. Zh Nevrol Psikhiatr Im S S Korsakova. 2015. PMID: 26726302.
6. Teichman SL, Neale A, Lawrence B, et al. *Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults*. J Clin Endocrinol Metab. 2006. PMID: 16352683.
7. Raun K, Hansen BS, Johansen NL, et al. *Ipamorelin, the first selective growth hormone secretagogue*. Eur J Endocrinol. 1998. PMID: 9849822.
8. Lee C, Zeng J, Drew BG, et al. *The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance*. Cell Metab. 2015. PMID: 25738459.
9. Alvarez XA, Cacabelos R, Sampedro C, et al. *Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease*. Eur J Neurol. 2011. PMID: 21425947.

Ready to go deeper?

If you want to run a protocol, start with the single-peptide beginner trial above, then escalate based on what you learn. Two cluster articles to read next:

• The full dsip dosage and timing guide (most useful first read)
• The cjc 1295 ipamorelin bedtime protocol (the GH stack done right)

When you are ready to source, every peptide on this list has its own profile page on Peptide.best with vetted vendors, per-batch COAs, and price comparison. Start with the dsip or ipamorelin profile.

Sleep is not a luxury and it is not unfixable. The intervention layer most people have not tried -- carefully, with measurement -- is sitting right here.